EQNRX
Price
$23.18
Change
+$0.08 (+0.35%)
Updated
Jul 25 closing price
Net Assets
668.42M
RMFCX
Price
$60.41
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
Interact to see
Advertisement

EQNRX vs RMFCX

Header iconEQNRX vs RMFCX Comparison
Open Charts EQNRX vs RMFCXBanner chart's image
MFS Equity Income R1
Price$23.18
Change+$0.08 (+0.35%)
VolumeN/A
Net Assets668.42M
American Funds American Mutual R3
Price$60.41
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
EQNRX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EQNRX vs. RMFCX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNRX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 111B vs. EQNRX (668M). RMFCX pays higher dividends than EQNRX: RMFCX (1.27) vs EQNRX (1.19). EQNRX was incepted earlier than RMFCX: EQNRX (13 years) vs RMFCX (23 years). EQNRX (1.70) is less costly to investors than RMFCX (0.91). EQNRX is a more actively managed with annual turnover of: 45.00 vs. RMFCX (31.00). EQNRX has a lower initial minimum investment than RMFCX: EQNRX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 11.38 vs. EQNRX (7.77). EQNRX (60.60) and RMFCX (60.49) have equivalent 5 years return.
EQNRXRMFCXEQNRX / RMFCX
Total Expense Ratio1.640.91180%
Annual Report Gross Expense Ratio1.700.91187%
Fund Existence13 years23 years-
Gain YTD10.72311.34794%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets668M111B1%
Annual Yield % from dividends1.191.2794%
Returns for 1 year7.7711.3868%
Returns for 3 years34.3230.87111%
Returns for 5 years60.6060.49100%
Returns for 10 years90.8781.82111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRML19.771.02
+5.44%
Tourmaline Bio
MNY2.050.07
+3.54%
MoneyHero Limited
RRX154.44N/A
N/A
Regal Rexnord Corp
BDRX0.88-0.01
-0.58%
Biodexa Pharmaceuticals plc
VNET8.26-0.48
-5.49%
VNET Group